NCT02682667
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +31 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,069 public trials
582 recruiting studies
Hemostatic Disorders trial results
NCT07099391
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT06158841
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham - Main /ID# 261434 Birmingham, Alabama, United States
- Mayo Clinic Hospital - Phoenix /ID# 263326 Phoenix, Arizona, United States
- Alta Bates Summit Medical Center for Research /ID# 261438 Berkeley, California, United States
- Providence - St. Jude Medical Center /ID# 262031 Fullerton, California, United States
NCT04898790
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +20 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
Recruiting
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
NCT05135351
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Unversity of Nebraska Medical Center Omaha, Nebraska, United States
NCT07227311
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- GSK Investigational Site Los Alamitos, California, United States
- GSK Investigational Site Torrance, California, United States
- GSK Investigational Site Whittier, California, United States
- GSK Investigational Site Fort Myers, Florida, United States
NCT04728893
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +24 more
- Locations
-
- Highlands Oncology Group ( Site 2728) Springdale, Arkansas, United States
- University of California San Diego Moores Cancer Center ( Site 2717) La Jolla, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site 2724) Torrance, California, United States
- Colorado Blood Cancer Institute ( Site 2726) Denver, Colorado, United States
NCT07116616
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
- UCSF San Francisco, California, United States
- Emory University Hospital Atlanta, Georgia, United States
- Mass General Brigham Boston, Massachusetts, United States
Recruiting
18F-Fluciclovine PET/CT in Multiple Myeloma
NCT06103838
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States